<!DOCTYPE html>
<html lang="en">
  <head>
            
   

<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<meta http-equiv="X-UA-Compatible" content="ie=edge" />

<link rel="shortcut icon" href="/wiki/assets/favicon.ico" type="image/x-icon" />

<title>Mixed Connective Tissue Disease • Kang Rui Xiang's Notes</title>

<meta name="description" content="This is my wiki page" />

<meta property="og:title" content="Mixed Connective Tissue Disease • Kang Rui Xiang's Notes" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://kangruixiang.github.io/wiki//notes/Mixed Connective Tissue Disease/" />
<meta property="og:image" content="/assets/avatar.png" />
<meta property="og:description" content="This is my wiki page" />

<link rel="canonical" href="https://kangruixiang.github.io/wiki//notes/Mixed Connective Tissue Disease/" />

<link rel="stylesheet" href="/wiki/style.css" />

<style>
  @font-face {
    font-family: "Concourse";
    src: url("/wiki/assets/fonts/concourse_3_regular.woff2") format("woff2");
    font-style: normal;
  }
  @font-face {
    font-family: "Equity";
    src: url("/wiki/assets/fonts/equity_a_regular.woff2") format("woff2");
    font-style: normal;
  }
</style>

  </head>
  <body class="h-screen bg-ember scroll-smooth">
    <div
      class="fixed top-0 w-screen"
    >
    <div class="flex items-center justify-between max-w-4xl px-4 py-4 mx-auto md:px-10 bg-ember bg-opacity-90">
     <a href="/wiki/"> <svg xmlns="http://www.w3.org/2000/svg" class="w-8 h-8" viewBox="0 0 20 20" fill="currentColor">
  <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z" />
</svg></a>

      <nav class="flex space-x-2 font-semibold uppercase">
        <a href="/wiki/" class="p-4 rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Home</a
        >
        <a
          href="/wiki/notes/Step 1"
          class="p-4 font-semibold rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Step 1</a
          >
      </nav>
    </div>
    </div>

    <div class="flex items-center justify-center flex-none max-w-4xl px-6 mx-auto mt-32 mb-32">
      <div  class="font-serif prose prose-lg prose-h1:text-xl prose-h2:text-lg md:prose-2xl md:prose-h1:text-4xl md:prose-h2:text-3xl prose-hr:border-zinc-900 hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200"><h1 id="mixed-connective-tissue-disease" tabindex="-1">Mixed Connective Tissue Disease</h1>
<ul>
<li>related: <a href="/wiki/notes/Rheumatology/">Rheumatology</a></li>
<li>tags: #rheumatology</li>
</ul>
<hr>
<h2 id="overview" tabindex="-1">Overview</h2>
<p>Despite long-standing attempts to define rheumatologic diseases according to precise classification, some patients express only nonspecific, nondiagnostic signs and symptoms (undifferentiated connective tissue disease UCTD), whereas others experience features of more than one disease simultaneously (overlap syndromes). Mixed connective tissue disease (MCTD) is a specific overlap syndrome that includes clinical manifestations of at least two of the following: systemic lupus erythematosus (SLE), polymyositis, and systemic sclerosis. Positive anti-U1-ribonucleoprotein (RNP) antibodies are the primary laboratory feature.</p>
<p>See <strong><a href="https://mksap18.acponline.org/app/topics/rm/tables/mk18_a_rm_t32">Table 32</a></strong> for a comparison of MCTD, UCTD, and overlap syndromes.</p>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220314084628.png" alt=""></p>
<h2 id="epidemiology-and-pathophysiology" tabindex="-1">Epidemiology and Pathophysiology</h2>
<p>MCTD is rare, and 80% of patients are women. B-cell abnormalities and an association between anti-U1-RNP antibody titer and disease activity have been described.</p>
<h2 id="clinical-manifestations-and-diagnosis" tabindex="-1">Clinical Manifestations and Diagnosis</h2>
<p>See <strong><a href="https://mksap18.acponline.org/app/topics/rm/tables/mk18_a_rm_t32">Table 32</a></strong> for details on the clinical manifestations and diagnosis of MCTD. Raynaud phenomenon is a particularly common feature. Pulmonary arterial hypertension is the major cause of death, but severe kidney disease is uncommon. Although antinuclear antibodies, rheumatoid factor, and anti–cyclic citrullinated peptide antibodies are often present, the presence of anti–double-stranded DNA or anti-Smith antibodies make SLE a more likely diagnosis.</p>
<h2 id="management" tabindex="-1">Management</h2>
<p>Treatment for MCTD is directed at the specific diseases and organ system involvement manifesting in the individual patient (see <strong><a href="https://mksap18.acponline.org/app/topics/rm/tables/mk18_a_rm_t32">Table 32</a></strong>).</p>
<h2 id="prognosis" tabindex="-1">Prognosis</h2>
<p>Prognosis of MCTD varies depending on the spectrum and severity of organ involvement. Patients with initially mild disease may develop new and more severe manifestations over decades, importantly including interstitial lung disease and pulmonary arterial hypertension. As with many other systemic inflammatory disorders, patients are at increased risk of atherosclerotic cardiovascular disease.</p>
<p>UCTD usually remains mild and stable but over time may evolve into a more specific autoimmune disorder, most commonly SLE.</p>

      </div>
    </div>
    
     <div class="fixed hidden ml-8 right-[5%] 2xl:block top-48 border-l-2 border-zinc-600 px-2"> 
        <nav class="toc" >
        <ul><li><a href="#overview">Overview</a></li><li><a href="#epidemiology-and-pathophysiology">Epidemiology and Pathophysiology</a></li><li><a href="#clinical-manifestations-and-diagnosis">Clinical Manifestations and Diagnosis</a></li><li><a href="#management">Management</a></li><li><a href="#prognosis">Prognosis</a></li></ul>
      </nav>
      </div>


    <div class="max-w-4xl p-2 mx-auto font-sans font-semibold uppercase bg-emberdark">Backlinks</div>
    <div class="mx-auto font-serif prose prose-lg hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200">
      
      <!-- <hr /> -->



<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Rheumatology/" class="peer">Rheumatology</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="rheumatology" tabindex="-1">Rheumatology</h1>
<ul>
<li>related: <a href="/wiki/notes/Medicine/">Medicine</a></li>
</ul>
<hr>
<ul>
<li><a href="/wiki/notes/Approach%20to%20the%20Patient%20with%20Rheumatologic%20Disease/">Approach to the Patient with Rheumatologic Disease</a></li>
<li><a href="/wiki/notes/Principles%20of%20Therapeutics/">Principles of Therapeutics</a></li>
<li><a href="/wiki/notes/Rheumatoid%20Arthritis/">Rheumatoid Arthritis</a></li>
<li><a href="/wiki/notes/Osteoarthritis/">Osteoarthritis</a></li>
<li><a href="/wiki/notes/Fibromyalgia/">Fibromyalgia</a></li>
<li><a href="/wiki/notes/Spondyloarthritis/">Spondyloarthritis</a></li>
<li><a href="/wiki/notes/Systemic%20Lupus%20Erythematosus/">Systemic Lupus Erythematosus</a></li>
<li><a href="/wiki/notes/Sjogren%20Syndrome/">Sjogren Syndrome</a></li>
<li><a href="/wiki/notes/Inflammatory%20Myopathies/">Inflammatory Myopathies</a></li>
<li><a href="/wiki/notes/Systemic%20Sclerosis/">Systemic Sclerosis</a></li>
<li><a href="/wiki/notes/Mixed%20Connective%20Tissue%20Disease/">Mixed Connective Tissue Disease</a></li>
<li><a href="/wiki/notes/Crystal%20Arthropathies/">Crystal Arthropathies</a></li>
<li><a href="/wiki/notes/Infectious%20Arthritis/">Infectious Arthritis</a></li>
<li><a href="/wiki/notes/Systemic%20Vasculitis/">Systemic Vasculitis</a></li>
<li>[[Other Rheumatolog</li>
</ul>

      </div>
    </div>
  </li>
  
</ul>


</div>

    <footer>
      <div class="max-w-6xl mx-auto mb-10 text-sm text-center mt-96">
        By Kang Rui Xiang
      </div>
      </div>
    </footer>
  </body>
</html>
